Open AccessContrast-enhanced ultrasound diagnosis of prostatic sarcoma
Author(s) -
Guozhu Wu,
Ran Sun,
Hong Hua,
Yumin Wang,
Jing Li,
Qian Liu,
Aitong Sun
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024038
Subject(s) - medicine , prostatectomy , sarcoma , radiology , contrast enhanced ultrasound , prostate , ultrasound , radiation therapy , brachytherapy , pathology , cancer
Rationale: Prostatic sarcoma (PS) is a very rare malignant tumor that accounts for <0.1% of prostate malignancies, and Ewing's sarcoma is an extremely rare form of PS. Patient concerns: We reported on a 64-year-old patient with PS and a 36-year-old patient with Ewing's sarcoma, both of whom were examined by contrast-enhanced ultrasonography (CEUS) before surgery. Diagnoses: The 2 cases were proven to be prostatic stromal sarcoma, which was confirmed by imaging manifestations and histopathological findings. Interventions: The 64-year-old patient underwent radical prostatectomy, and the 36-year-old patient underwent chemotherapy combined with local radiotherapy. Outcomes: PS showed diffuse enlargement of the prostate on sonography, and the necrotic liquefying area within the large vessels could be clearly displayed by CEUS. CEUS can be advocated as a valuable noninvasive and safe imaging diagnosis method for PS.